IO Frontiers World 2019


Joanne Bedwell-Garner

Dr Joanne Bedwell-Garner

Development Director, Macrophage Pharma

Dr Bedwell-Garner brings over 25 years’ experience in the pharmaceutical sector, having held numerous senior Research and Development roles at companies including BTG, where she was Vice President of Non-Clinical Development and was responsible for non-clinical evaluation and translation into the clinic. Prior to this she held senior roles at Protherics, Emergent BioSolutions and Microscience. Dr Bedwell-Garner has a successful track record in taking greater than 15 pre-clinical candidates into clinical development; particularly in the areas of oncology, inflammation, cardiovascular and infectious disease. She obtained a PhD in oncology from University of London.


  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy